Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy Toxicity”

399 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 399 results

Testing effectiveness (Phase 2)Study completedNCT00057811
What this trial is testing

Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Diffuse Large Cell LymphomaChildhood Immunoblastic Large Cell Lymphoma+9 more
Children's Oncology Group 97
Post-approval studies (Phase 4)Looking for participantsNCT07158164
What this trial is testing

DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment

Who this might be right for
Colorectal NeoplasmsBreast NeoplasmsHead and Neck Neoplasms+1 more
Rutgers, The State University of New Jersey 100
Not applicableStudy completedNCT03480087
What this trial is testing

Subclinical Cardio-toxicities Evaluation With Strain Rate Echocardiography After Chemotherapy and/or Mediastinal Radiotherapy in Patient With Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinHodgkin LymphomaToxicity, Cardiac
A.O.U. Città della Salute e della Scienza 118
Not applicableLooking for participantsNCT04474964
What this trial is testing

Focal Radiotherapy Plus Low Dose Craniospinal Irradiation Followed by Adjuvant Chemotherapy in WNT Medulloblastoma.

Who this might be right for
Medulloblastoma, WNT-activated
Tata Memorial Centre 30
Not applicableActive Not RecruitingNCT07184047
What this trial is testing

Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers

Who this might be right for
Gastrointestinal CancersFrailtySarcopenia in Elderly+8 more
Ankara Etlik City Hospital 72
Testing effectiveness (Phase 2)UnknownNCT03785704
What this trial is testing

Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast NeoplasmsCardiac EventChemotherapeutic Toxicity
Peking Union Medical College 60
Early research (Phase 1)Study completedNCT01445535
What this trial is testing

Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas

Who this might be right for
T-Cell Peripheral LymphomaGamma Delta Hepatosplenic T-Cell LymphomaSubcutaneous Panniculitis-Like T-Cell Lymphoma+1 more
National Cancer Institute (NCI) 15
Not applicableNot Yet RecruitingNCT06986291
What this trial is testing

Radiation-induced Toxicity of the Heart

Who this might be right for
Non-small Cell Lung CancerEsophageal CancerBreast Cancer Female
Technische Universität Dresden 325
Testing effectiveness (Phase 2)Study completedNCT05316818
What this trial is testing

Triplet (FOLFOXIRI) vs. Doublet (FOLFOX or FOLFIRI) Regimen as a 1st Line Treatment in Metastatic Colorectal Carcinoma

Who this might be right for
Metastatic Colorectal Cancer
Kasr El Aini Hospital 64
Post-approval studies (Phase 4)Study completedNCT00138060
What this trial is testing

Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants

Who this might be right for
Metastatic Colorectal Cancer
Institut de Recherche Clinique sur les Cancers et le Sang 71
Not applicableUnknownNCT01863420
What this trial is testing

The Effect of Bone Marrow-sparing Intensity-Modulated Radiotherapy to GI Cancer

Who this might be right for
Rectal CancerGastric CancerBone Marrow Toxicity+1 more
Chinese Academy of Medical Sciences 58
Not applicableEnded earlyNCT00679874
What this trial is testing

Assessment of Cardiotoxicity After Chemotherapy for Breast Cancer by Cardio-vascular Magnetic Resonance (MR)

Who this might be right for
Breast Cancer
University of Calgary 66
Early research (Phase 1)Ended earlyNCT00238173
What this trial is testing

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ+1 more
OHSU Knight Cancer Institute 2
Not applicableStudy completedNCT04528745
What this trial is testing

The Relationship Between Fat Free Mass and Toxicity of Cytostatics in Cancer Patients

Who this might be right for
Pancreas CancerColorectal Cancer
University of Copenhagen 52
Large-scale testing (Phase 3)Ended earlyNCT03512756
What this trial is testing

Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tyme, Inc 130
Early research (Phase 1)Study completedNCT00003144
What this trial is testing

Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health 44
Testing effectiveness (Phase 2)Study completedNCT02745639
What this trial is testing

Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer

Who this might be right for
Rectal Neoplasms
IRCCS Azienda Ospedaliero-Universitaria di Bologna 18
Not applicableStudy completedNCT02849912
What this trial is testing

Signal Detection in Monoclonal and New Agents in Lymphoma

Who this might be right for
Lymphoma
Centre Hospitalier Universitaire de Nice 1,671
Not applicableStudy completedNCT03858712
What this trial is testing

EHR-embedded OCDT in Breast or GI Cancer

Who this might be right for
Oral Cancer Directed TherapyBreast CancerGastrointestinal Cancer+1 more
Dana-Farber Cancer Institute 100
Post-approval studies (Phase 4)Ended earlyNCT00754767
What this trial is testing

L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityNeurotoxicity
HealthPartners Institute 2
Load More Results